Downloads

1. Fadool DA, Tucker K, Perkins R, et al. Kv1.3 channel gene-targeted deletion produces "Super-Smeller Mice" with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron. 2004;41(3):389-404. 2. Xu J, Wang P, Li Y, et al. The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci U S A. 2004;101(9):3112-3117. 3. Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev. 2009;231(1):59-87. 4. Upadhyay SK, Eckel-Mahan KL, Mirbolooki MR, et al. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A. 2013;110(24):E2239-2248. 5. Beeton C, Wulff H, Standifer NE, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A. 2006;103(46):17414-17419. 6. Sarkar S, Nguyen HM, Malovic E, et al. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease. J Clin Invest. 2020;130(8):4195-4212. 7. Leanza L, Henry B, Sassi N, et al. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med. 2012;4(7):577-593. 8. Teisseyre A, Palko-Labuz A, Sroda-Pomianek K, Michalak K. Voltage-Gated Potassium Channel Kv1.3 as a Target in Therapy of Cancer. Front Oncol. 2019;9:933. 9. Maruyama Y. A patch-clamp study of mammalian platelets and their voltage-gated potassium current. J Physiol. 1987;391:467-485. 10. Mahaut-Smith MP, Rink TJ, Collins SC, Sage SO. Voltage-gated potassium channels and the control of membrane potential in human platelets. J Physiol. 1990;428:723-735. 11. McCloskey C, Jones S, Amisten S, et al. Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count. J Physiol. 2010;588(Pt 9):1399-1406. 12. Wright JR, Amisten S, Goodall AH, Mahaut-Smith MP. Transcriptomic analysis of the ion channelome of human platelets and megakaryocytic cell lines. Thromb Haemost. 2016;116(2):272-284. 13. Kawa K. Voltage-gated calcium and potassium currents in megakaryocytes dissociated from guinea-pig bone marrow. J Physiol. 1990;431:187-206. 14. Romero E, Sullivan R. Complexity of the outward K+ current of the rat megakaryocyte. Am J Physiol. 1997;272(5 Pt 1):C1525-1531. 15. Kapural L, Feinstein MB, O'Rourke F, Fein A. Suppression of the delayed rectifier type of voltage gated K+ outward current in megakaryocytes from patients with myelogenous leukemias. Blood. 1995;86(3):1043-1055. 16. Fan C, Yang X, Wang WW, et al. Role of Kv1.3 Channels in Platelet Functions and Thrombus Formation. Arterioscler Thromb Vasc Biol. 2020;40(10):2360-2375. 17. Koni PA, Khanna R, Chang MC, et al. Compensatory anion currents in Kv1.3 channel-deficient thymocytes. J Biol Chem. 2003;278(41):39443-39451. 18. Pugh N, Simpson AM, Smethurst PA, de Groot PG, Raynal N, Farndale RW. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood. 2010;115(24):5069-5079. 19. Sahli K, Flora GD, Sasikumar P, et al. Structural, Functional and Mechanistic Insights Uncover the Fundamental Role of Orphan Connexin62 in Platelets. Blood. 2020. 20. Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res. 2007;100(12):1673-1685. 21. Farndale RW. Collagen-induced platelet activation. Blood Cells Mol Dis. 2006;36(2):162-165. 22. McEver RP, Zhu C. Rolling cell adhesion. Annu Rev Cell Dev Biol. 2010;26:363-396. 23. Aslan JE, McCarty OJ. Rho GTPases in platelet function. J Thromb Haemost. 2013;11(1):35-46. 24. Rosen ED, Raymond S, Zollman A, et al. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. Am J Pathol. 2001;158(5):1613-1622. 25. Celi A, Merrill-Skoloff G, Gross P, et al. Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy. J Thromb Haemost. 2003;1(1):60-68. 26. Falati S, Gross PL, Merrill-Skoloff G, et al. In vivo models of platelet function and thrombosis: study of real-time thrombus formation. Methods Mol Biol. 2004;272:187-197. 27. Josefsson EC, White MJ, Dowling MR, Kile BT. Platelet life span and apoptosis. Methods Mol Biol. 2012;788:59-71. 28. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004;104(6):1606-1615. 29. Pugh N, Bihan D, Perry DJ, Farndale RW. Dynamic analysis of platelet deposition to resolve platelet adhesion receptor activity in whole blood at arterial shear rate. Platelets. 2015;26(3):216-219. 30. Lickert S, Sorrentino S, Studt JD, Medalia O, Vogel V, Schoen I. Morphometric analysis of spread platelets identifies integrin alphaIIbbeta3-specific contractile phenotype. Sci Rep. 2018;8(1):5428. 31. McCarty OJ, Larson MK, Auger JM, et al. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem. 2005;280(47):39474-39484. 32. Akbar H, Shang X, Perveen R, et al. Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation. PLoS One. 2011;6(7):e22117. 33. Barkalow KL, Falet H, Italiano JE, Jr., et al. Role for phosphoinositide 3-kinase in Fc gamma RIIA-induced platelet shape change. Am J Physiol Cell Physiol. 2003;285(4):C797-805. 34. Pleines I, Hagedorn I, Gupta S, et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood. 2012;119(4):1054-1063. 35. Farndale RW, Lisman T, Bihan D, et al. Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions. Biochem Soc Trans. 2008;36(Pt 2):241-250. 36. Levite M, Cahalon L, Peretz A, et al. Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med. 2000;191(7):1167-1176. 37. Matheu MP, Beeton C, Garcia A, et al. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity. 2008;29(4):602-614. 38. Kindzelskii AL, Petty HR. Ion channel clustering enhances weak electric field detection by neutrophils: apparent roles of SKF96365-sensitive cation channels and myeloperoxidase trafficking in cellular responses. Eur Biophys J. 2005;35(1):1-26. 39. Fraser SP, Diss JK, Lloyd LJ, et al. T-lymphocyte invasiveness: control by voltage-gated Na+ channel activity. FEBS Lett. 2004;569(1-3):191-194. 40. Carrithers MD, Chatterjee G, Carrithers LM, et al. Regulation of podosome formation in macrophages by a splice variant of the sodium channel SCN8A. J Biol Chem. 2009;284(12):8114-8126. 41. Fraser SP, Diss JK, Chioni AM, et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res. 2005;11(15):5381-5389. 42. Brackenbury WJ, Calhoun JD, Chen C, et al. Functional reciprocity between Na+ channel Nav1.6 and beta1 subunits in the coordinated regulation of excitability and neurite outgrowth. Proc Natl Acad Sci U S A. 2010;107(5):2283-2288. 43. Chioni AM, Brackenbury WJ, Calhoun JD, Isom LL, Djamgoz MB. A novel adhesion molecule in human breast cancer cells: voltage-gated Na+ channel beta1 subunit. Int J Biochem Cell Biol. 2009;41(5):1216-1227. 44. Davis TH, Chen C, Isom LL. Sodium channel beta1 subunits promote neurite outgrowth in cerebellar granule neurons. J Biol Chem. 2004;279(49):51424-51432. 45. Sasikumar P, AlOuda KS, Kaiser WJ, et al. The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and hemostasis. J Thromb Haemost. 2018;16(5):946-959. 46. Solovjov DA, Pluskota E, Plow EF. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem. 2005;280(2):1336-1345. 47. Watson SP. Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des. 2009;15(12):1358-1372. 48. Hechler B, Gachet C. P2 receptors and platelet function. Purinergic Signal. 2011;7(3):293-303. 49. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173-1186. 50. Zhang H, Nimmer PM, Tahir SK, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 2007;14(5):943-951. 51. Szabo I, Bock J, Jekle A, et al. A novel potassium channel in lymphocyte mitochondria. J Biol Chem. 2005;280(13):12790-12798. 52. Szabo I, Bock J, Grassme H, et al. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci U S A. 2008;105(39):14861-14866. 53. Gulbins E, Sassi N, Grassme H, Zoratti M, Szabo I. Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim Biophys Acta. 2010;1797(6-7):1251-1259. 54. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol. 1992;98(6):637-646. 55. Lakkis N, Dokainish H, Abuzahra M, et al. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol. 2004;44(10):2091-2093. 56. Watson SP, Harrison P, Halford GM. Editorial policy during the lockdown. Platelets. 2020;31(4):411. 57. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2007;21(2):99-111. 58. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007;100(1):27-40. 59. Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol. 2012;34(1):5-30. 60. Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol. 2013;35(3):254-261. 61. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis. 1997;25(5):951-968; quiz 969-970. 62. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4(6):445-457. 63. Gaertner F, Ahmad Z, Rosenberger G, et al. Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria. Cell. 2017;171(6):1368-1382 e1323. 64. Yeaman MR, Bayer AS. Antimicrobial peptides from platelets. Drug Resist Updat. 1999;2(2):116-126. 65. Semple JW, Italiano JE, Jr., Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264-274. 66. DeCoursey TE, Chandy KG, Gupta S, Cahalan MD. Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature. 1984;307(5950):465-468. 67. Wulff H, Pennington M. Targeting effector memory T-cells with Kv1.3 blockers. Curr Opin Drug Discov Devel. 2007;10(4):438-445. 68. Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015;33:291-353. 69. Kazama I, Tamada T, Tachi M. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases. Inflamm Res. 2015;64(10):753-765. 70. Chandy KG, Norton RS. Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease. Curr Opin Chem Biol. 2017;38:97-107. 71. Braeuninger S, Kleinschnitz C, Nieswandt B, Stoll G. Focal cerebral ischemia. Methods Mol Biol. 2012;788:29-42. 72. Chen YJ, Nguyen HM, Maezawa I, Jin LW, Wulff H. Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke. Ann Clin Transl Neurol. 2018;5(2):147-161.